Pan Xiaohua, Liu Guorong, Wu Bo, Liu Xiuzhen, Fang Yong
Department of Neurology, West China Hospital, Sichuan University, Chengdu, Sichuan.
Department of Neurology, Baotou Central Hospital, Baotou, Inner Mongolia, China.
Medicine (Baltimore). 2019 Apr;98(14):e14956. doi: 10.1097/MD.0000000000014956.
Whether bridging strategies[intravenous thrombolysis (IVT) + mechanical thrombectomy (MT)] are superior to mechanical thrombectomy alone for large vessel occlusion(LVO) is still uncertain. A systematic review and meta-analysis was conducted to investigate and evaluate comparative efficacy and safety of bridging strategies vs direct MT in patients with LVO.
The PubMed, EMBASE and Cochrane library databases were searched to evaluate the efficacy and safety of bridging strategies with direct MT in LVO. Functional independence, mortality, symptomatic intracranial hemorrhage (sICH) and successful recanalization were assessed. The risk ratio (RR) and its 95% confidence interval (CI) were calculated.
The proportion of patients who received MT + IVT was significantly higher in functional independence and successful recanalization rate than MT alone patients. However, pooled results showed that the mortality of patients who received MT + IVT was significantly lower than that of MT alone patients. Moreover, no significant differences were observed in the incidence of sICH between the 2 groups.
The findings of our meta-analysis confirmed that bridging strategies improved functional outcomes, successful recanalization rate and reduced mortality rates. Moreover, the incidence of sICH showed no differences between the bridging strategies and MT alone treatments. However, the conduct of high-quality randomized clinical trials that directly compare both strategies is warranted.
对于大血管闭塞(LVO)患者,桥接策略(静脉溶栓[IVT]+机械取栓[MT])是否优于单纯机械取栓仍不确定。进行了一项系统评价和荟萃分析,以调查和评估桥接策略与直接机械取栓在LVO患者中的疗效和安全性比较。
检索PubMed、EMBASE和Cochrane图书馆数据库,以评估桥接策略联合直接机械取栓在LVO中的疗效和安全性。评估功能独立性、死亡率、症状性颅内出血(sICH)和成功再通情况。计算风险比(RR)及其95%置信区间(CI)。
接受MT+IVT的患者在功能独立性和成功再通率方面显著高于单纯MT患者。然而,汇总结果显示,接受MT+IVT的患者死亡率显著低于单纯MT患者。此外,两组间sICH发生率无显著差异。
我们的荟萃分析结果证实,桥接策略改善了功能结局、成功再通率并降低了死亡率。此外,桥接策略与单纯MT治疗之间的sICH发生率无差异。然而,有必要开展直接比较这两种策略的高质量随机临床试验。